Additional Metadata
Persistent URL dx.doi.org/10.1016/j.eururo.2018.12.019, hdl.handle.net/1765/116333
Journal European Urology : Official Journal of the European Association of Urology
Citation
Zuiverloon, T.C.M, & Theodorescu, D. (2019). Re: Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy. European Urology : Official Journal of the European Association of Urology, 75(4), 694–694. doi:10.1016/j.eururo.2018.12.019